Superior Biologics

Overview
News
Hospital-at-Home?
Product stageSegments
Go-to-Market
?
Medication Management, Home Care Workflow
?

Superior Biologics, founded in 2012, is a provider of specialty pharmacy and home infusion therapy services for patients with chronic illnesses. The company specializes in intravenous immunoglobin (IVIG) and Factor for hemophilic patients, while also supporting infusion therapies for diseases in neurology, oncology, gastroenterology, rheumatology, and dermatology. Superior Biologics operates a network of accredited pharmacies across the US, offering prescription delivery services to all 50 states and the District of Columbia. The company's business model focuses on providing innovative and cost-effective pharmacy and in-home nursing infusion services, aiming to achieve optimal therapeutic outcomes and deliver high-quality patient results.

Superior Biologics utilizes technology to streamline care for patients and reduce the administrative burden on healthcare providers. The company's approach involves a combination of high-touch personal services and advanced technology to improve patient wellness. As of December 2022, Superior Biologics operated seven accredited pharmacies across the US, serving patients in 43 states. The company's pharmacies have earned accreditations from the Accreditation Commission for healthcare (ACHC), The Joint Commission (TJC), and the Utilization Review Accreditation Commission (URAC), demonstrating its commitment to maintaining high standards of care and service quality.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
200 Saw Mill River Road Hawthorne NY USA
Founded year:
2012
Employees:
101-250
IPO status:
Private
Total funding:
USD 185.6 mn
Last Funding:
USD 135.6 mn (Debt Financing; Dec 2022)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.